28-OXO-H2B1A IVERMECTIN (25 mg) ((2aE,4E,5’S,6S,6’R,7S, 8E,11R,13R,15S,17aR,20R,20aR,20bS)-6’-(S)-sec-Butyl-20,20b-dihydroxy-5’,6,8,19-tetramethyl-2,17-dioxo-3’,4’,5’,6,6’,7,10,11,14,15,17a,20,20a,20b-tetradecahydrospiropyran-2’,13-[11,15]methano[1,5]dioxacyclooctadecino[9,8,7-cd]benzofuran-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-3-O-methyl-α-L-arabino-hexopyranoside )

In Stock

Ready to ship

Catalogue No.

1A13270

CAS No.

102190-55-6

Molecular Formula

C₄₈H₇₂O₁₅

Product Type

Pharmaceutical Analytical Impurities

$1,750.00

Shipping information

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Additional information

Current Lot Information

Current Lot:

F27480

CAS RN®

102190-55-6

Harmonized System (HS) Code *:

29322090

UN No:

N/A

NDC No:

N/A

Molecular Formula

C₄₈H₇₂O₁₅

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS:

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No	USP Certificates/Product Information Sheets and Valid Use Dates	Valid Use Date	Country of Origin*	Material Origin*
F27480	1A13270-F27480	See Product Information Sheet	India	Chemical Synthesis


Lot No F27480	USP Certificates/Product Information Sheets and Valid Use Dates Chemical Synthesis
Valid Use Date See Product Information Sheet
Country of Origin* India
Material Origin* No data available

Lot No

F27480

USP Certificates/Product Information Sheets and Valid Use Dates

Chemical Synthesis

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

No data available

Frequently bought together

28-OXO-H2B1A IVERMECTIN (25 mg) ((2aE,4E,5’S,6S,6’R,7S, 8E,11R,13R,15S,17aR,20R,20aR,20bS)-6’-(S)-sec-Butyl-20,20b-dihydroxy-5’,6,8,19-tetramethyl-2,17-dioxo-3’,4’,5’,6,6’,7,10,11,14,15,17a,20,20a,20b-tetradecahydrospiropyran-2’,13-[11,15]methano[1,5]dioxacyclooctadecino[9,8,7-cd]benzofuran-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-3-O-methyl-α-L-arabino-hexopyranoside )

Catalogue No.

1A13270

CAS No.

102190-55-6

Molecular Formula

C₄₈H₇₂O₁₅

Product Type

Pharmaceutical Analytical Impurities

$1,750.00

EPOXY BETAMETHASONE

Catalogue No.

1A10160

CAS No.

981-34-0

Molecular Formula

C₂₂H₂₈O₅

Product Type

Pharmaceutical Analytical Impurities

$712.50

DIMETHYL FELODIPINE

Catalogue No.

1A10130

CAS No.

91189-59-2

Molecular Formula

C₁₇H₁₇Cl₂NO₄

Product Type

Pharmaceutical Analytical Impurities

$712.50

TOFACITINIB DIMER (25 mg) (1,3-Bis{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-1,3-propanedione)

ETORICOXIB (100 mg) (5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine )

OLAPARIB DIMER (25 mg) (4,4'-{[(Piperazine-1,4-dicarbonyl)bis(4-fluoro-3,1-phenylene)]bis(methylene)}bis(phthalazin-1(2H)-one))

RANOLAZINE 1N-OXIDE (25 mg) (1-(2-((2,6-Dimethylphenyl)amino)-2-oxoethyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazine 1-oxide)

CINACALCET ACID

LINAGLIPTIN 3-METHYL PHTHALIMIDE

TENOFOVIR ENANTIOMER (25 mg) ((S)-(1-(6-Amino-9H-purin-9-yl)propan-2-yloxy)methylphosphonic acid)

N,N-DIDESETHYL SUNITINIB HYDROCHLORIDE (25 mg) (N-(2-Aminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide hydrochloride (1:1))

LENVATINIB ACID (25 mg) (4-(3-Chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxylic acid)

Product Description

Additional information

Current Lot Information

Product Information

Frequently bought together

DICLOFENAC ALCOHOL

O-ACETYL IOPAMIDOL

1-HYDROXY-2-NAPHTHOIC ACID

PROMETHAZINE SULFOXIDE

Recently Viewed

Got any Queries?

Product Description

Additional information

Current Lot Information

Product Information

Frequently bought together

Related Products

DICLOFENAC ALCOHOL

O-ACETYL IOPAMIDOL

1-HYDROXY-2-NAPHTHOIC ACID

PROMETHAZINE SULFOXIDE

Recently Viewed

TOFACITINIB DIMER (25 mg) (1,3-Bis{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-1,3-propanedione)

ETORICOXIB (100 mg) (5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine )

OLAPARIB DIMER (25 mg) (4,4'-{[(Piperazine-1,4-dicarbonyl)bis(4-fluoro-3,1-phenylene)]bis(methylene)}bis(phthalazin-1(2H)-one))

RANOLAZINE 1N-OXIDE (25 mg) (1-(2-((2,6-Dimethylphenyl)amino)-2-oxoethyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazine 1-oxide)

CINACALCET ACID

LINAGLIPTIN 3-METHYL PHTHALIMIDE

TENOFOVIR ENANTIOMER (25 mg) ((S)-(1-(6-Amino-9H-purin-9-yl)propan-2-yloxy)methylphosphonic acid)

N,N-DIDESETHYL SUNITINIB HYDROCHLORIDE (25 mg) (N-(2-Aminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide hydrochloride (1:1))

LENVATINIB ACID (25 mg) (4-(3-Chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxylic acid)

Got any Queries?